Loading
AI
Akouos, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 01 Dec 2022.
Akouos, Inc.: what insiders have been doing
Akouos, Inc. has a thin disclosure history in our data (latest filing: 2 December 2022). New filings will appear here as soon as they are published. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
17
Thresholds
n/a
Buy Volume
€363M
1 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 2 December 2022
Declarations17 total
5,882 sharesCommon StockSEC:0001104659-22-124137:0
4,294,207 sharesCommon StockSEC:0001209191-22-059458:0
12,338 sharesCommon StockSEC:0001104659-22-124145:0
82,385 sharesCommon StockSEC:0001104659-22-124134:0
4,294,207 sharesCommon StockSEC:0001209191-22-059450:0
4,294,207 sharesCommon StockSEC:0001209191-22-059461:0
3,153,333 sharesCommon StockSEC:0001104659-22-124136:0
4,294,207 sharesCommon StockSEC:0001209191-22-059446:0
4,294,207 sharesCommon StockSEC:0001209191-22-059460:0
26,930 sharesCommon StockSEC:0001104659-22-124141:0
4,294,207 sharesCommon StockSEC:0001209191-22-059454:0
4,294,207 sharesCommon StockSEC:0001209191-22-059440:0
272,582 sharesCommon StockSEC:0001104659-22-124140:0
4,294,207 sharesCommon StockSEC:0001209191-22-059442:0
4,294,207 sharesCommon StockSEC:0001209191-22-059452:0
3,153,333 sharesCommon StockSEC:0001209191-22-059372:0
29,992,668 shares@ US$12.50100.0% of flowCommon StockSEC:0000899243-22-037279:0
Canonical exit: 28 Feb 2023 (T+90)
17 of 17 declarations
About Akouos, Inc.
Akouos, Inc. is a biopharmaceutical company focused on developing gene therapies to treat hearing disorders. It is listed on the NASDAQ under the ticker symbol AKUS.
